Related references
Note: Only part of the references are listed.The prevalence and pattern of chemotherapy-induced peripheral neuropathy among women with breast cancer receiving care in a large community oncology practice
Natalie B. Simon et al.
QUALITY OF LIFE RESEARCH (2017)
A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I
Deirdre R. Pachman et al.
SUPPORTIVE CARE IN CANCER (2017)
Limb Hypothermia for Preventing Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot Study
Raghav Sundar et al.
FRONTIERS IN ONCOLOGY (2017)
Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients
Scott M. Monfort et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Quantitative Sensory Testing at Baseline and During Cycle 1 Oxaliplatin Infusion Detects Subclinical Peripheral Neuropathy and Predicts Clinically Overt Chronic Neuropathy in Gastrointestinal Malignancies
Sangeetha M. Reddy et al.
CLINICAL COLORECTAL CANCER (2016)
The effectiveness of regional cooling for paclitaxel-induced peripheral neuropathy
Junya Sato et al.
JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES (2016)
Cancer treatment-related neuropathic pain: proof of concept study with menthol-a TRPM8 agonist
M. T. Fallon et al.
SUPPORTIVE CARE IN CANCER (2015)
A Quantitative Sensory Analysis of Peripheral Neuropathy in Colorectal Cancer and Its Exacerbation by Oxaliplatin Chemotherapy
Mariana de Carvalho Barbosa et al.
CANCER RESEARCH (2014)
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Cryotherapy for docetaxel-induced hand and nail toxicity: randomised control trial
Alexandra L. McCarthy et al.
SUPPORTIVE CARE IN CANCER (2014)
Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience
Bhavana Bhatnagar et al.
SPRINGERPLUS (2014)
Chemotherapy-Induced Peripheral Neurotoxicity: A Critical Analysis
Susanna B. Park et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine
Jessica A. Boyette-Davis et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Impact of Chemotherapy-Induced Peripheral Neuropathy on Treatment Delivery in Nonmetastatic Breast Cancer
Rebecca M. Speck et al.
JOURNAL OF ONCOLOGY PRACTICE (2013)
Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients
H. Ishiguro et al.
SUPPORTIVE CARE IN CANCER (2012)
Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients
Rebecca M. Speck et al.
SUPPORTIVE CARE IN CANCER (2012)
The Brief Pain Inventory: revealing the effect of cancer pain
Michael I. Bennett
LANCET ONCOLOGY (2009)
Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies
Sherry Wolf et al.
EUROPEAN JOURNAL OF CANCER (2008)
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations
Robert H. Dworkin et al.
JOURNAL OF PAIN (2008)
Quantitative sensory findings in patients with bortezomib-induced pain
Juan P. Cata et al.
JOURNAL OF PAIN (2007)
Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain
Patrick M. Dougherty et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2007)
Quantitative sensory testing: a comprehensive protocol for clinical trials
R Rolke et al.
EUROPEAN JOURNAL OF PAIN (2006)
Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand
F Scotté et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AN1424) to prevent chemotherapy induced peripheral neuropathy
ID Davis et al.
CLINICAL CANCER RESEARCH (2005)
Development and validation of the neuropathic pain symptom inventory
D Bouhassira et al.
PAIN (2004)
Neurophysiological study of peripheral neuropathy after high-dose paclitaxel: Lack of neuroprotective effect of amifostine
H Openshaw et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
